Bristol Myers Squibb Co (BMY) Holder Willingdon Wealth Management Boosted Holding by $956,466; Matthews International Capital Management Lifted Its Stake in Netease (NTES) as Share Price Declined

August 12, 2018 - By Kristin Houston

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Willingdon Wealth Management increased its stake in Bristol Myers Squibb Co (BMY) by 21.58% based on its latest 2018Q1 regulatory filing with the SEC. Willingdon Wealth Management bought 15,182 shares as the company’s stock declined 23.11% with the market. The institutional investor held 85,550 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $5.41 million, up from 70,368 at the end of the previous reported quarter. Willingdon Wealth Management who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $96.79B market cap company. The stock decreased 0.37% or $0.22 during the last trading session, reaching $59.31. About 3.54 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 2.98% since August 12, 2017 and is downtrending. It has underperformed by 15.55% the S&P500. Some Historical BMY News: 09/04/2018 – Keytruda is already approved to treat several forms of cancer, including advanced melanoma. The drug racked up $3.81 billion in revenue in 2017; 12/03/2018 – Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors; 05/03/2018 – Rhode Island DoA: Bristol Warren Regional School District Mon, 3/5/2018, 6:00 PM; 06/04/2018 – INCYTE- SAFETY PROFILE OBSERVED IN ECHO-301/KEYNOTE-252 WAS CONSISTENT WITH THAT OBSERVED IN STUDIES OF EPACADOSTAT IN COMBINATION WITH KEYTRUDA; 02/05/2018 – Bristol-Myers Squibb and Biogen Are the Pharmas Most Trusted by Doctors, Study Finds; 24/05/2018 – IDERA PHARMACEUTICALS – WILL SPONSOR, FUND, CONDUCT CO’S OPEN-LABEL, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF TILSOTOLIMOD IN COMBINATION WITH YERVOY; 25/04/2018 – Rhode Island DoA: Bristol Fourth of July Committee Wed, 4/25/2018, 7:00 PM; 30/04/2018 – Merck Seeks Approval for Keytruda Combo as First-Line Treatment for Metastatic Nonsquamous NSCLC; 15/05/2018 – OMEGA ADDED TMO, UNH, ANDV, BMY, BC IN 1Q: 13F; 05/04/2018 – Rhode Island DoA: Bristol Town Council Thu, 4/5/2018, 7:30 PM

Matthews International Capital Management Llc increased its stake in Netease Inc (NTES) by 1.41% based on its latest 2018Q1 regulatory filing with the SEC. Matthews International Capital Management Llc bought 3,500 shares as the company’s stock declined 25.93% with the market. The institutional investor held 251,200 shares of the miscellaneous company at the end of 2018Q1, valued at $70.43M, up from 247,700 at the end of the previous reported quarter. Matthews International Capital Management Llc who had been investing in Netease Inc for a number of months, seems to be bullish on the $29.51B market cap company. The stock decreased 0.24% or $0.55 during the last trading session, reaching $224.67. About 1.78M shares traded or 59.91% up from the average. NetEase, Inc. (NASDAQ:NTES) has declined 22.10% since August 12, 2017 and is downtrending. It has underperformed by 34.67% the S&P500. Some Historical NTES News: 16/05/2018 – Netease 1Q EPS 91c; 27/03/2018 – China’s internet tiger NetEase aims to make retail as big as games; 26/03/2018 – BEIJING — Chinese internet technology services provider NetEase will try to maintain double-digit growth by making its online retail arm as large as its core mobile games business, according to CEO and founder William Ding Lei; 16/05/2018 – NETEASE 1Q ADJ EARNINGS PER ADS $1.61, EST. $2.15; 22/05/2018 – Franklin Dynatech Adds DocuSign Inc., Exits Netease; 14/05/2018 – Comgest Exits Criteo, Cuts Netease, Buys More Cognizant: 13F; 17/05/2018 – ADRs End Mostly Lower; NetEase Trades Actively; 27/04/2018 – NetEase Youdao Completes Its First Strategic Funding, Getting the Firm Admitted into the “Unicorn” Club with a Valuation of $1; 27/03/2018 – BEIJING — One of China’s most promising internet companies, NetEase, will try to maintain double-digit growth by making its online retail arm as large as its core mobile games business, according to CEO and founder William Ding Lei; 15/05/2018 – Chinese cross-border e-commerce operator NetEase Kaola facilitates sales of made in Japan products in China

Matthews International Capital Management Llc, which manages about $24.94B and $2.21B US Long portfolio, decreased its stake in Tal Ed Group (NYSE:XRS) by 28,600 shares to 155,000 shares, valued at $5.75 million in 2018Q1, according to the filing. It also reduced its holding in Taiwan Semiconductor Mfg Ltd (NYSE:TSM) by 473,324 shares in the quarter, leaving it with 2.90 million shares, and cut its stake in Altaba Inc.

Among 20 analysts covering NetEase (NASDAQ:NTES), 13 have Buy rating, 4 Sell and 3 Hold. Therefore 65% are positive. NetEase had 52 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of NetEase, Inc. (NASDAQ:NTES) earned “Overweight” rating by JP Morgan on Thursday, February 25. The firm earned “Buy” rating on Wednesday, April 25 by CLSA. The stock of NetEase, Inc. (NASDAQ:NTES) has “Hold” rating given on Thursday, September 29 by Jefferies. Vetr upgraded NetEase, Inc. (NASDAQ:NTES) rating on Wednesday, August 12. Vetr has “Hold” rating and $148.56 target. The rating was initiated by Goldman Sachs with “Buy” on Wednesday, November 25. Jefferies maintained NetEase, Inc. (NASDAQ:NTES) on Thursday, November 16 with “Hold” rating. The stock of NetEase, Inc. (NASDAQ:NTES) has “Outperform” rating given on Monday, October 3 by CLSA. The firm has “Buy” rating by Benchmark given on Thursday, May 17. As per Monday, September 21, the company rating was maintained by Credit Suisse. The firm has “Buy” rating by Standpoint Research given on Monday, January 9.

More notable recent NetEase, Inc. (NASDAQ:NTES) news were published by: Seekingalpha.com which released: “NetEase Is A Chinese Hedge Against New Tariffs” on August 09, 2018, also Benzinga.com with their article: “68 Stocks Moving In Thursday’s Mid-Day Session” published on August 09, 2018, Benzinga.com published: “77 Biggest Movers From Yesterday” on August 10, 2018. More interesting news about NetEase, Inc. (NASDAQ:NTES) were released by: Seekingalpha.com and their article: “NetEase -9.2% after revenues lag high growth expectations” published on August 09, 2018 as well as Seekingalpha.com‘s news article titled: “NetEase, Inc 2018 Q2 – Results – Earnings Call Slides” with publication date: August 09, 2018.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Fool.com which released: “3 Beaten-Down Biotech Stocks: Can They Recover?” on August 12, 2018, also Seekingalpha.com with their article: “BeiGene launches late-stage study of tislelizumab in first-line lung cancer” published on August 09, 2018, 247Wallst.com published: “Short Sellers Hike Bets in Major Pharma Stocks” on August 10, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Benzinga.com and their article: “Q2 Earnings Preview For Bristol-Myers Squibb” published on July 25, 2018 as well as Seekingalpha.com‘s news article titled: “Premarket analyst action – healthcare” with publication date: August 08, 2018.

Since April 30, 2018, it had 1 buy, and 0 sales for $249,948 activity.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 1 Sell and 15 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 90 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Neutral” rating by Credit Suisse on Friday, July 27. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, December 1. The rating was maintained by Jefferies with “Hold” on Monday, February 26. The rating was maintained by Jefferies on Tuesday, June 14 with “Hold”. The rating was initiated by Societe Generale with “Sell” on Wednesday, April 6. On Monday, March 5 the stock rating was maintained by Bank of America with “Neutral”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Sell” rating by BMO Capital Markets on Wednesday, August 16. Hilliard Lyons downgraded the stock to “Hold” rating in Tuesday, September 12 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Wednesday, August 16 by Credit Suisse. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Thursday, August 11 by Berenberg.

Investors sentiment decreased to 0.83 in 2018 Q1. Its down 0.11, from 0.94 in 2017Q4. It dropped, as 64 investors sold BMY shares while 573 reduced holdings. 111 funds opened positions while 418 raised stakes. 1.12 billion shares or 1.08% more from 1.11 billion shares in 2017Q4 were reported. Hightower Advsr Lc has invested 0.49% in Bristol-Myers Squibb Company (NYSE:BMY). Decatur has invested 2% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Appleton Partners Ma has 0.19% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 19,404 shares. Schnieders Capital Mngmt Ltd Liability Co accumulated 0.41% or 15,000 shares. Kbc Nv holds 371,225 shares. Lourd Capital Ltd Llc reported 36,891 shares. The Arizona-based Mutual Of Omaha Commercial Bank Wealth has invested 0.21% in Bristol-Myers Squibb Company (NYSE:BMY). Prudential Public Ltd Liability Com stated it has 0% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Stonebridge Advsr Limited Co has 1.19% invested in Bristol-Myers Squibb Company (NYSE:BMY). Commonwealth Of Pennsylvania Public School Empls Retrmt has 0.13% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 146,086 shares. Legacy Private Trust Company invested in 0.14% or 19,300 shares. Haverford Co stated it has 86,613 shares or 0.11% of all its holdings. Shine Investment Advisory Incorporated has invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). First City Cap Management holds 40,207 shares or 1.9% of its portfolio. Cadinha And Limited Com holds 2.73% in Bristol-Myers Squibb Company (NYSE:BMY) or 213,923 shares.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts